{"transactions":[{"id":1723414,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2023-12-04T22:00:26.000Z","date":"2023-12-01","kind":"exercise","planned":false,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022, with a further 25% having vested on December 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022, with a further 25% having vested on December 1, 2023."}],"balance_after":16666,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001209191-23-057258","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123057258/doc4.xml","form_type":"4"}},{"id":1723413,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2023-12-04T22:00:26.000Z","date":"2023-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2933,"price":2.12,"value":6217.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs."}],"balance_after":10369,"source":{"system":"sec-edgar","filing":"0001209191-23-057258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123057258/doc4.xml","form_type":"4"}},{"id":1723412,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2023-12-04T22:00:26.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":13302,"source":{"system":"sec-edgar","filing":"0001209191-23-057258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123057258/doc4.xml","form_type":"4"}},{"id":1931790,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T00:00:13.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1,"expiration_date":"2033-03-30","underlying":"Ordinary Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-022421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123022421/doc4.xml","form_type":"4"}},{"id":2095512,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2022-12-05T22:00:33.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022."}],"balance_after":24999,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001209191-22-059733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122059733/doc4.xml","form_type":"4"}},{"id":2095511,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-05T22:00:33.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":3365,"price":1.32,"value":4441.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":4969,"source":{"system":"sec-edgar","filing":"0001209191-22-059733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122059733/doc4.xml","form_type":"4"}},{"id":2095510,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-05T22:00:33.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022, the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported on this Form 4 have been adjusted to reflect the Reverse Share Split"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":8334,"source":{"system":"sec-edgar","filing":"0001209191-22-059733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122059733/doc4.xml","form_type":"4"}},{"id":2472855,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2021-12-14T22:00:19.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date and the other terms and conditions of the Issuer's 2021 Inducement Equity Incentive Plan, the RSUs shall vest over four years with 25% of the RSUs vesting on each one-year anniversary of December 1, 2021, such that the total number of RSUs shall be fully vested by December 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date and the other terms and conditions of the Issuer's 2021 Inducement Equity Incentive Plan, the RSUs shall vest over four years with 25% of the RSUs vesting on each one-year anniversary of December 1, 2021, such that the total number of RSUs shall be fully vested by December 1, 2025."}],"balance_after":500000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-21-069494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919121069494/doc4.xml","form_type":"4"}},{"id":2472854,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-12-14T22:00:19.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":1800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of December 1, 2021 and the remaining 75% will vest in equal monthly installments thereafter until December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date."}],"balance_after":1800000,"derivative":{"exercise_price":0.48,"expiration_date":"2031-12-09","underlying":"Ordinary Shares","underlying_shares":1800000},"source":{"system":"sec-edgar","filing":"0001209191-21-069494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919121069494/doc4.xml","form_type":"4"}},{"id":2763305,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Options - Right to Buy","published_at":"2021-04-01T20:42:48.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":71250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 30, 2022, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":71250,"derivative":{"exercise_price":7.02,"expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":71250},"source":{"system":"sec-edgar","filing":"0001213900-21-019700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390021019700/ownership.xml","form_type":"4"}},{"id":3192803,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":107768,"kind":"person","name":"Puttagunta Sailaja","position":1,"cik":"0001792314","reported_name":"Puttagunta Sailaja","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Options - Right to Buy","published_at":"2020-03-27T20:00:49.000Z","date":"2020-03-25","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include 263,576 additional options previously granted to the Reporting Person which have different exercise prices and which vest on different schedules."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The options are held by SPB Consulting LLC. The Reporting Person is the sole member of SPB Consulting LLC and may be deemed the indirect beneficial owner of the securities held by SPB Consulting LLC."}],"balance_after":67500,"derivative":{"exercise_price":6.21,"expiration_date":"2030-03-25","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001213900-20-007663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390020007663/ownership.xml","form_type":"4"}}]}